Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for seizure control in refractory epilepsy
IRCT20200825048515N63Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of fenofibrate in epilepsy, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Number of seizure attacks and EEG changes. Started Feb 2023; status: completed.
02
Drugs
fenofibrate
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20200825048515N63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N63.